January 16, 2003 |
I called it Vitamin P. Prozac, that is. The little green-and-cream-colored capsule that I took to dodge the blues. I didn't think of it as a serious psychotropic drug. I thought it belonged on the food pyramid. If Time magazine proves prophetic, that may turn out not to have been such a far-fetched idea. Before long, we may all be taking it. In a Jan.
January 13, 2003 |
The recent approval of Prozac for children and teenagers means more of them are likely to be treated for depression and obsessive-compulsive disorder. It also means that many could be treated inappropriately. The Food and Drug Administration's decision to allow the drug to be prescribed for kids 7 to 17 will encourage more primary-care doctors, pediatricians and family-practice doctors to prescribe the antidepressant. That could especially benefit children who lack access to psychiatrists.
January 4, 2003 |
Prozac is now formally available for depressed children. Psychiatrists have prescribed the world's best-known antidepressant, and similar competitors, to their youngest patients for years, despite a shortage of studies proving they work in children. But the Food and Drug Administration declared that there's finally proof that Prozac alleviates depression in children 8 years and older.
CALIFORNIA | LOCAL
December 12, 2002 |
Call it a tree for what ails ya. It graces the counter of the Memorial Medical Group office in Long Beach and it's festooned with tiny empty boxes. Boxes that held prescription drugs. There are even antidepressant containers, perhaps to cheer up Scrooge types. And the decoration at the top? It's a Viagra box. O, Christmas tree! More cheer: Marty Rauch of West L.A.
November 25, 2002 |
I know a psychiatrist who took antidepressant medication (plenty of us do, though few admit it). When at his best, he imagined himself a poet, someone who wore a white coat in sunlight and composed quatrains by candle. Then, in the mysterious way that depression descends, he became ill. Still, the poems were passionate. For years, he had been prescribing Prozac and its many cousins: Zoloft, Paxil, Celexa, Luvox. He knew how the drugs worked, and that they worked well.
October 24, 2002 |
Eli Lilly & Co. cut profit forecasts after competition from cheaper, generic versions of its antidepressant Prozac pushed sales lower in the third quarter. Full-year profit, excluding one-time items, probably will be $2.55 to $2.57 a share, Lilly said. The company has lowered 2002 forecasts three times in six months and is "cautious" about 2003 as regulators reassess plants that failed inspections, stalling drug approvals. Net income jumped 20% to $683.9 million, or 63 cents a share, from $570.
July 4, 2002 |
WASHINGTON -- A Florida woman opened her mailbox last month to find a free box of once-a-week Prozac from her pharmacy chain--astonishing, she says, since she didn't use Prozac and hadn't asked her doctor to switch her from another antidepressant. It's not clear how many other patients received unsolicited Prozac (the woman's attorneys say they know of two more so far) or whether the apparent campaign to sign up new Prozac customers extended beyond South Florida. Prozac maker Eli Lilly & Co.
April 18, 2002 |
A man on trial for killing seven co-workers tripled his dosage of Prozac before the shootings, a move that may have heightened his rage and sparked the shooting spree, a defense psychiatrist testified Wednesday. Dr. Anthony Joseph said Michael McDermott suffers from paranoid schizophrenia and other mental disorders that made him unable to understand that what he was doing was wrong when he opened fire at Edgewater Technology on Dec. 26, 2000.
January 19, 2002 |
Eli Lilly & Co. settled charges it violated the privacy of 669 people who took its anti-depression drug Prozac by disclosing the e-mail address of each patient to the others. The Federal Trade Commission said the drug maker agreed to implement procedures to ensure it would not repeat the inadvertent disclosure in June of the e-mail addresses of the Prozac users. The company may be subject to $11,000 in daily fines if it violates the agreement. Lilly shares dropped 84 cents to close at $74.
January 15, 2002 |
The U.S. Supreme Court rejected Eli Lilly & Co.'s appeal of a patent ruling that allowed generic drug maker Barr Laboratories Inc. to sell a version of the antidepressant Prozac. The justices let stand a U.S. appeals court ruling that resulted in Lilly losing patent protection in August for Prozac, which in recent years has boosted the company into the top 10 U.S. drug makers. Barr, based in Pomona, N.Y.